Medexus Pharmaceuticals (FRA:P731) Cyclically Adjusted PB Ratio : 1.20 (As of Jun. 20, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-20), Medexus Pharmaceuticals's current share price is €1.04. Medexus Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €0.87. Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.20.

The historical rank and industry rank for Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:P731' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.79 Med: 4.15 Max: 11.37
Current: 1.11

During the past years, Medexus Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 11.37. The lowest was 0.79. And the median was 4.15.

FRA:P731's Cyclically Adjusted PB Ratio is ranked better than
69.85% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs FRA:P731: 1.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medexus Pharmaceuticals's adjusted book value per share data for the three months ended in Dec. 2023 was €1.108. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.87 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation

Medexus Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cyclically Adjusted PB Ratio

Get a 7-Day Free Trial

10.11

1.10

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cyclically Adjusted PB Ratio	Get a 7-Day Free Trial															11.06	1.10	1.29	2.15	1.77

Competitive Comparison of Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.

Medexus Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio	=	Share Price	/	Cyclically Adjusted Book per Share
	=	1.04	/	0.87
	=	1.20

Medexus Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Medexus Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book	=	Book Value per Share	/	CPI of Dec. 2023 (Change)	*	Current CPI (Dec. 2023)
	=	1.108	/	125.0724	*	125.0724
	=	1.108

Current CPI (Dec. 2023) = 125.0724.

Medexus Pharmaceuticals Quarterly Data

	Book Value per Share	CPI	Adj_Book
201312	0.981	96.945	1.266
201406	0.946	99.473	1.189
201409	0.808	99.394	1.017
201412	0.675	98.367	0.858
201503	0.681	99.789	0.854
201506	0.457	100.500	0.569
201509	0.318	100.421	0.396
201512	0.160	99.947	0.200
201603	0.402	101.054	0.498
201606	0.617	102.002	0.757
201609	0.520	101.765	0.639
201612	0.406	101.449	0.501
201703	0.188	102.634	0.229
201706	0.617	103.029	0.749
201709	0.578	103.345	0.700
201712	0.467	103.345	0.565
201803	0.327	105.004	0.389
201806	0.268	105.557	0.318
201809	-0.127	105.636	-0.150
201812	2.504	105.399	2.971
201903	1.680	106.979	1.964
201906	1.569	107.690	1.822
201909	1.660	107.611	1.929
201912	1.470	107.769	1.706
202003	1.520	107.927	1.761
202006	1.245	108.401	1.436
202009	1.092	108.164	1.263
202012	0.244	108.559	0.281
202103	0.790	110.298	0.896
202106	0.497	111.720	0.556
202109	1.036	112.905	1.148
202112	1.027	113.774	1.129
202203	0.810	117.646	0.861
202206	0.833	120.806	0.862
202209	0.856	120.648	0.887
202212	0.723	120.964	0.748
202303	1.039	122.702	1.059
202306	1.034	124.203	1.041
202309	0.856	125.230	0.855
202312	1.108	125.072	1.108

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Medexus Pharmaceuticals (FRA:P731) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.

Medexus Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (FRA:P731) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Cyclically Adjusted PB Ratio

Comparable Companies

Traded in Other Exchanges

MEDXF:USA MDP:Canada

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Medexus Pharmaceuticals (FRA:P731) Headlines

No Headlines